Business ❯ Finance ❯ Securities ❯ Class Action Lawsuits

Investor Rights

Navan IPO Lawsuit Intensifies as Firms Seek Investors Before April 24 Lead-Plaintiff Deadline

The case alleges the IPO materials hid a 39% spike in sales-plus-marketing costs that preceded a steep post-IPO share slide.

Stories older than 24h

Kyndryl Class Action Moves Forward With April 13 Lead-Plaintiff Deadline

Richtech Robotics Faces Securities Class Action Over Microsoft Tie as Firms Seek Lead Plaintiff

Richtech Robotics Securities Case Accelerates After Microsoft Denial as Firms Seek Lead Plaintiff

Coupang Securities Suits Jockey for Lead as Feb. 17 Investor Deadline Nears

CoreWeave Faces Securities Class Action Over Data-Center Delays and Demand Claims

Alexandria Real Estate Investors Face Jan. 26 Deadline in LIC Disclosure Class Action

Bath & Body Works Faces Investor Class Action Over 'Adjacencies' Claims With Lead‑Plaintiff Motions Due in March

Sprouts Investors Face Jan. 26 Deadline to Seek Lead Role in Securities Class Action

Investor Alerts Intensify as Lead-Plaintiff Deadline Nears in DeFi Technologies Securities Case

Alexandria Real Estate Class Action Intensifies Ahead of Jan. 26 Lead-Plaintiff Deadline

Law Firms Press Lead-Plaintiff Drive in Klarna IPO Class Action

Klarna Faces IPO Lawsuit Over Credit-Risk Disclosures After Loss Provisions Surge

Bitdeer Investors Pressed to Act as Lead‑Plaintiff Deadline Nears in SEAL04 Securities Case

Law Firms Seek Sprouts Investors as Jan. 26 Lead‑Plaintiff Deadline Nears

Multiple Securities Class Actions Target Coupang Over Alleged Undisclosed Cyber Breach

Stride Investors Face Jan. 12 Deadline in Securities Class Action Over Enrollment and Tech Claims

Marex and CarMax Securities Suits Enter Lead‑Plaintiff Phase With New Deadlines

Plaintiffs’ Firms Step Up Marex Class-Action Push Before Dec. 8 Lead-Plaintiff Cutoff

DexCom Faces Wave of Securities Class Actions Over FDA-Faulted CGM Changes